Introduction 70
Healthcare workers (HCWs) are considered the most trusted source of vaccine-related 71 information(1). However, studies are showing that HCWs are losing confidence in 72 vaccination for their children, themselves, or their patients(2-5). Public health experts refer to 73 this loss of confidence as "vaccine hesitancy", which has recently been defined by the SAGE 74
Working Group on Vaccine Hesitancy as "a behaviour, influenced by a number of factors 75 including issues of confidence, complacency, and convenience."(6) Vaccine hesitant HCWs 76
can have a powerful influence on vaccination decisions, as they might recommend vaccines 77 less frequently to their patients, and/or otherwise undermine confidence and contribute to 78 vaccine hesitancy among the general population(2). 79
The little available research on HCWs' attitudes is primarily related to seasonal and/or 80 pandemic influenza vaccines. Most found that HCWs had not taken the influenza vaccine 81 because of lack of time (7, 8) , not feeling at risk of influenza (9, 10), because they 82 considered they had no medical indication for the vaccine (4, 5), or due to concerns about 83 safety and efficacy (3, 11) . 84
This research aims to better understand vaccine hesitancy among vaccine providers in 85
Europe, and explore the nature of their concerns, their perceptions of vaccine-related 86 information, and their perceived role in responding to vaccine hesitancy. 87 88
Methods 89
The study was conducted in Croatia, France, Greece and Romania, as these countries 90 responded to ECDC's call for interest in participating in the project entitled "Comprehensive 91 expert opinion on motivating hesitant population groups to vaccinate". These countries have 92 very different socio-economic and political backgrounds, allowing a more comprehensive 93 overview of vaccine hesitancy in various contexts. Semi-structured interviews were 94 conducted with healthcare providers who advise on vaccination for children, pregnant 95 women and adults and who were working in one of the selected countries at the time of 96 study. Healthcare professionals who only administer the vaccine, after the patient has 97 already decided to receive it, were not included. Recruitment of participants was done to 98 include vaccine providers that are either vaccine hesitant or that face vaccine hesitancy in 99 their practice. The aim was to build a sample of the general population of vaccine providers 100 in each country to understand what their concerns about vaccines might be and how they 101 respond to patient hesitancy. Areas with known vaccine hesitancy or low vaccination 102 coverage were purposively favoured to increase the likelihood of recruiting healthcare 103 workers either facing hesitancy or being hesitant themselves. The aim was not to determine 104 levels of hesitancy in healthcare workers. Due to varying quality and quantity of data 105 available on vaccination coverage rates and vaccine hesitancy in the different countries, 106 different sampling methods were used in each country. In Croatia and Romania, the 107 assumption that vaccine hesitancy exists across the whole country was used to select 108 participants as there was no available data on specific levels of hesitancy in different regions 109 and populations. In France, MMR vaccine coverage rates were used as a proxy for vaccine 110 hesitancy. In Greece, this was done by using snowball sampling and first contacting two 111 vaccine hesitancy vaccine providers. Based on the time and budget available for the study, 112 and recommended sampling strategies for qualitative research, each country was asked to 113 recruit approximately 15 HCWs, selected purposively. 114 A 30-minute interview guide, with a consent form and information sheet, was sent to country 115 teams for translation and adaptation. The questions, which were not piloted due to time 116 constraints, were designed to be neutral (i.e. "Have you ever had a patient who was hesitant 117 or opposed to get himself/herself or his/her children vaccinated?", "Do you think that some 118 vaccines which are officially recommended are not necessary?"). Face-to-face interviews 119 were conducted at a location chosen by the participant, recorded with their approval, and 120 transcribed removing identifiers such as names and locations using an automated 121 programme or manually where software was not available. Interviewers in all countries were 122 trained experienced researchers in qualitative interviewing. 123 
Sampling methods 124

Results
164
Sixty-five semi-structured interviews were conducted across Croatia (17/65), France (16/65), 165
Greece (15/65) and Romania (17/65). Most participants were female (66%) and between 25-166 44 years old (58%). The majority were GPs (72%), with gynaecologists (9%), 167 epidemiologists (6%), paediatricians (6%) and internal medicine specialists (6%) also 168 participating (Table 1) . 169 170 mentioned that there might be too many vaccines (C=1;F=2;G=11;R=5) given to children at 209 a very young age (C=1;F=3;G=6;R=2), which led some interviewed doctors to follow their 210 own vaccination plans in Greece. 211
Trust issues were raised in Greece, Romania, and Croatia and to a lesser extent in France. 212
In Croatia, France and Romania, the majority of these positively referred to trust in the 213 government, health authorities, doctors or research (C=17;F=8;G=6;R=12), and in 214 vaccination (C=17;F=4;G=5;R=11). In Croatia and Greece, trust in information received by 215
HCWs from various sources was also observed. Mistrust was extremely prevalent in Greece, 216 especially towards pharmaceutical companies (C=2;F=4;G=11;R=7). Interviewed HCWs in 217 all countries believed pharmaceutical companies have financial interests, put pressure on 218
HCWs, and do not provide sufficient information about side effects. A mistrust of health 219 authorities (C=0;F=3;G=9;R=4) and information about vaccination (C=0;F=3;G=7;R=6) was 220 also observed among some of the interviewed French, Romanian and Greek HCWs. One 221
Greek respondent commented, "I do not trust the Greek Ministry of Health and rightly so. 222
Many patients do not trust them either." (G12). 223
HCWs in Croatia and Romania were particularly pleased with the quantity and quality of 224 information they receive or give to patients through leaflets, posters, books or websites 225 (C=13;F=1;G=3;R=11). However, other HCWs in Romania and in Greece also reported a 226 lack of information about safety and the risks of receiving too many vaccines to allow 227 patients to make an informed decision (C=4; F=2; G=8; R=7). A few doctors in Greece and 228
Romania (C=0, F=0, G=4, R=3) were also entirely against vaccination, two of which also 229 mentioned a preference for homeopathy or prescribing natural remedies. "I do not like 230
vaccines! I tell my patients that I've never vaccinated myself with any vaccine."(R1). 231
HCWs in Romania, Greece and France, and to a lesser extent in Croatia, discussed ways 232 they and their patients are influenced when making decisions about vaccination. HCWs in all 233 countries reported being influenced by their employers or health authorities in terms of 234 vaccination schedules or reminders (C=11; F=9; G=4; R=10). Influences by pharmaceutical 235 representatives who remind HCWs of vaccination schedules were mostly discussed in 236
France (C=0; F=12; G=0; R=2), where mistrust in pharmaceutical companies was not 237 reported as much as in other countries. One French HCW commented, "Pharmaceutical 238 drug representatives visit me; they explain to me how vaccines work, why a vaccine more 239 than another…" (F6), while another expressed some distrust. "I listen to (pharmaceutical) 240
companies but do not trust them" (F5). This shows that HCWs in France receive visits by 241
pharmaceutical representatives and use the information they provide, but do not necessarily 242 trust them. Influences from patient experiences (i.e. observing a lack of vaccine side effects 243 or infections with vaccine-preventable diseases) were reported in Greece and Romania. 244
Other influences mentioned were training courses, the media, online information, and 245 medical experts and journals. Some HCWs in Greece and Romania believed that their 246 patients were influenced by the media (C=0;F=1;G=3;R=13), HCWs (C=0;F=0;G=14;R=0), 247 and families, friends or partners (C=0;F=0;G=3;R=1). HCWs in Romania discussed the 248 negative, unverified and sometimes contradictory information available online which is 249 sometimes more persuasive than doctors: "With the increasing popularity of the Internet, 250 many parents are misinformed by charlatans and crooks that "seduce" them with false and 251
absurd information. (…) If some doctors were fooled by such misinformation, then parents 252 (…) are very vulnerable to such poisoning."(R5) 253
HCWs in all countries discussed their role in responding to patient hesitancy. In Croatia, 254
Greece and Romania, HCWs mostly believed that it is their role to address and respond to 255 patient hesitancy (C=17; F=4; G=13; R=11) by sharing "accurate and reliable information in 256 a way that they can understand" (C3). Some HCWs in Croatia, France and Romania, went 257 one step further and explained they have to try to influence patients' decision-making 258 regarding vaccination by emotionally affecting them (i.e. showing them images of 259 poliomyelitis cases), telling them they vaccinate their own children, or telling them 260 vaccination is mandatory (C=10; F=6; G=3; R=10): "I say it is mandatory even if it is not...
(…) I don't want to follow a child, a family who do not vaccinate their children" (F16). Some 262
HCWs, mostly in France, believed they should only provide neutral facts and information 263 about vaccination, without trying to influence or force patients to vaccinate (C=1; F=10; G=3; 264
R=4). 265
Overall, across all countries, HCWs came up with four major suggestions to improve 266 vaccination confidence: improve information, involve health authorities, ensure skilled 267 communication between HCWs and patients, and improve HCW training. 268
Discussion 269
The results from the qualitative interviews with HCWs from Croatia, France, Greece and 270
Romania confirm the study's initial assumption of existence of vaccine hesitancy among 271
HCWs and provide an insight into the reasons behind these doubts. Although the reports 272 from the interviews were overall positive and showed generally high levels of trust and 273 confidence in vaccination, there were also concerns about safety, questions about the need 274 for vaccines, and/or mistrust of pharmaceutical companies and health authorities. A few 275 doctors, some practicing homeopathy, were entirely against vaccination, and actively 276 decided not to recommend it to their patients. This is of particular concern as many studies 277 have shown that the attitude and knowledge HCWs have about vaccines can influence their 278 intentions to vaccinate themselves and their children, and to recommend vaccination to their 279 patients (12, 13). It is therefore highly important for public health leaders to find ways to 280 better understand HCW vaccine-related behaviours and attitudes and take steps to counter 281
hesitancy. 282
The most important concern across all countries was about vaccine safety. Most HCWs 283 reported these as concerns their patients have, but some shared similar worries. Many 284 studies have found that HCWs refuse vaccination because of the risk of side effects (11), but 285 also because they think they are at low risk of infection (15, 16). The latter was also 286 observed in this study, with HCWs lacking confidence in the need for and the effectiveness 287 of some vaccines, particularly the seasonal influenza one. HCWs have their patients' health 288 at heart, and it important that they are reminded of the dangers of vaccine-preventable 289 diseases and the low risks of vaccine side effects. 290
New vaccines, such as the HPV vaccine, were singled out due to perceived lack of testing 291 for vaccine safety and efficacy. This confirms previously conducted studies which also 292
showed HCWs' concerns about new vaccines (17, 18). The HPV vaccine is of particular 293 concern, as it is delivered by different HCWs in different countries. Making sure all vaccine 294 providers (nurses, gynaecologists, GPs, etc.) are included in the planning and deployment of 295 new vaccination campaign will alleviate their doubts and concerns, improve their knowledge 296 about the vaccine, and facilitate their recommendation to patients. 297
Another important theme which came across the interviews was trust. A 2015 French study 298 found that eight out of ten GPs trust the Ministry of Health but 50% of them also believe that 299 the Ministry is influenced by pharmaceutical companies (19). A similar scenario was found in 300 this study, with high trust expressed in the health authorities but mistrust of pharmaceutical 301 companies. Interviewed HCWs in Greece also showed high mistrust of the government and 302 health system, which could have been influenced by the political and economic crisis 303 situation in which the interviews were conducted and may require interventions to avoid 304 negative impact on vaccination uptake. This result demonstrates the importance of context in 305 vaccine hesitancy, and highlights the need for more cross-cutting research looking into the 306 impact of political, socio-economic and cultural contexts on concerns about vaccination. 307
Many institutions can be associated with vaccination and the public's credibility of vaccine 308 information will be influenced by their trust in some or all of these organisations and how 309 open and transparent these are. Trust can be built by expressing empathy and 310 acknowledging people's concerns and feelings and depends on the specific social, cultural, 311 political and economic context of the country or region affected. 312
HCWs stressed the issue of anti-vaccination content in the media and its influence on 313 patients. With continuous advancements in communication technologies such as social 314 media, the public is increasingly using the internet to research and share information about 315 vaccines. Some studies have analysed the content of vaccine information available on 316 websites and social media and have shown not only that it is of variable quality, but also that 317 there is a predominance of negative and sometimes incorrect content, which has the 318 potential to influence vaccine decisions (21-24). However, a study looking particularly at 319
French websites found that while some websites criticise some aspects of vaccines, not all 320 Increasing the presence of reliable sources of information online will allow countries to 324 counteract anti-vaccine groups and prevent them from reaching parents seeking more 325 information about vaccines on the internet. 326
Many interviewed vaccine providers felt it was their responsibility to respond to hesitant 327 patients, with some believing they should do even more and try to actively influence patients 328 to ensure they get vaccinated. However, in France, most study participants described their 329 role as providers of neutral information, explaining patients should make that decision for 330 themselves. HCWs are often seen as having the greatest influence on patients' decision to 331 get vaccinated. It is therefore important they not only communicate with hesitant patients, but 332 that they know how to respond to concerns or doubts. A study from 2011 concluded that 333
HCWs should aim to have open, non-confrontational dialogues with patients as early as 334 possible. It recommended using personal stories, reports of disease outbreaks and visual 335 images of individuals suffering from vaccine-preventable diseases to remind patients of the 336 need for high vaccination coverage (26) . 337 This study sheds light on current knowledge gaps that future research could explore further 338 such as varying opinions about vaccination among different types of vaccine providers, but 339 also in relation to different vaccines. The wide range of concerns raised related to vaccine 340 hesitancy points to the need for more comprehensive, context-specific interventions. While 341 most current interventions focus on education and improving information about vaccine 342 safety, effectiveness, or the need for vaccines, concerns raised in this study identify other 343 determinants of hesitancy that need addressing, such as trust in health systems, or HCWs' 344 perceived roles in responding to patient hesitancy and their levels of confidence in doing so. 345
Although some commonalities between countries can be found, determinants of hesitancy 346 have also been shown to be country-and context-specific and need to be addressed as 347
such. National vaccination programmes should consider developing the capacity of 348 identifying local determinants of vaccine hesitancy, whether in patients or in healthcare 349 workers and then developing strategies adapted to address these determinants, in a social, 350 cultural, political and economic context. 351
Limitations 353
There were a few limitations in this research. The first is the limited sample size and 354 differential sampling strategy in each country which may have affected the reliability of the 355 study. Recruitment of HCWs was also intentionally biased as it was done in geographical 356 areas where vaccination uptake was lower than average or where hesitancy was reported to 357 be more prevalent. Results for Greece must also be interpreted with caution as it was the 358 only country were vaccine hesitant providers were directly recruited through snowball 359 sampling. The representativeness of the views of the HCWs interviewed in this study must 360 be interpreted with caution, especially as they come from different healthcare systems, with 361 different approaches to vaccine provision. That said, the study's intent was to start 362 identifying the characteristics and experience of hesitancy among HCWs where vaccine 363 hesitancy and low vaccine uptake was known rather than quantify vaccine hesitancy. 
